Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Chris Atwood Foundation (CAF) is a 501(c)(3) non-profit organization dedicated to ending the stigma of addiction and preventing overdose deaths. Founded in 2013, the foundation provides essential harm reduction services, including the distribution of Narcan (naloxone), fentanyl test strips, and other life-saving supplies. CAF also offers peer recovery specialist services, community education, and advocacy for evidence-based drug policy. Based in Northern Virginia, the organization works to bridge the gap between active substance use and long-term recovery through low-barrier support and resource navigation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chris Atwood Foundation.